SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-019888
Filing Date
2020-08-03
Accepted
2020-08-03 16:04:39
Documents
3
Period of Report
2020-07-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124913-8k_inmunebio.htm 8-K 17311
2 PRESS RELEASE, DATED JULY 31, 2020 ea124913ex99-1_inmunebio.htm EX-99.1 7632
3 PRESS RELEASE, DATED AUGUST 3, 2020 ea124913ex99-2_inmunebio.htm EX-99.2 6482
  Complete submission text file 0001213900-20-019888.txt   32539
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 201069236
SIC: 2836 Biological Products, (No Diagnostic Substances)